Partner Headlines - ICPT

  1. Can-Fite An Emerging NASH Play With CF102

    TalkMarkets
  2. 5 Biotech Stocks to Watch as Interest in NASH Increases

    TalkMarkets
  3. Keep an Eye on These 7 Stocks for February 16, 2016

    Benzinga
  4. Benzinga's Weekend M&A Chatter

    Benzinga
  5. Intercept Pharma Spikes On Report That It’s Exploring A Sale

    IBD
  6. Intercept Pharmaceuticals Soars 30%; Reuters Reported Company ...

    Benzinga
  7. Benzinga's Top Upgrades

    Benzinga
  8. BioMarin, Intercept hit by FDA

    IBD
  9. BioMarin, Intercept Pharma Drugs Face FDA Delays

    IBD
  10. INTERCEPT PHARMA

    IBD
  11. Intercept Pharma Higher On Takeover Rumor

    Benzinga
  12. Intercept Presents New Data Analyses on Non-Invasive Liver Testing ...

    Benzinga
  13. Intercept Presents New Primary Biliary Cholangitis Data at AASLD ...

    Benzinga
  14. Benzinga's M&A Chatter for Tuesday November 10, 2015

    Benzinga
  15. Intercept Pharmaceuticals

    IBD
  16. Intercept Pharmaceuticals Rebounds After Phase 2 Trial Of OCA ...

    Benzinga
  17. Intercept Pharma NASH Drug Disappoints In Japan

    IBD
  18. Mid-Morning Market Update: Markets Open Higher; Hershey Earnings ...

    Benzinga
  19. Morning Market Losers

    Benzinga
  20. Mid-Morning Market Update: Markets Open Lower; Carlyle Group ...

    Benzinga
  21. Morning Market Gainers

    Benzinga
  22. FDA Grants Priority Review for Intercept's Obeticholic Acid for ...

    Benzinga
  23. CNBC's Meg Tirrel Speculates About Gilead's New Acquisiton

    Benzinga
  24. Sportsman's Warehouse, Bob Evans, Peabody Energy Lead Tuesday's ...

    Benzinga
  25. Benzinga's Top Initiations

    Benzinga
  26. Barclays Initiates Intercept Pharmaceuticals With Overweight

    Benzinga
  27. Intercept Pharmaceuticals Inc (ICPT) Moves Forward With OCA REGENERATE ...

    GuruFocus
  28. Intercept has a design for test

    IBD
  29. Intercept's NASH Trial Design Irks Investors

    IBD
  30. Will The Bulls In Options Continue To Be Disappointed This Week?

    Benzinga
  31. Analysts are Positive on Intercept Pharmaceuticals Inc Following ...

    GuruFocus
  32. Earnings Scheduled For March 2, 2015

    Benzinga
  33. Making Money With Charles Payne: 02/06/15

    FoxBusiness
  34. Wedbush Highlights 2015 Catalysts for Emerging BioPharmaceuticals ...

    GuruFocus
  35. Cowen And Company Analyst Explains Why Intercept Pharmaceuticals ...

    Benzinga
  36. Cowen Analyst Likes Intercept Pharmaceuticals, ACADIA Pharmaceuticals ...

    Benzinga
  37. Mid-Afternoon Market Update: Crude Oil Jumps 7.5%; Visa Shares ...

    Benzinga
  38. Intercept Pharmaceuticals Soars 20%, Possible Short Squeeze

    Benzinga
  39. Mid-Day Market Update: Amazon Jumps On Upbeat Earnings; Hawaiian ...

    Benzinga
  40. Intercept Pharmaceuticals (ICPT) Obeticholic Acid Momentum, Gigamon ...

    GuruFocus
  41. Benzinga's Volume Movers

    Benzinga
  42. Mid-Morning Market Update: Markets Drop; Mastercard Profit Tops ...

    Benzinga
  43. Morning Market Gainers

    Benzinga
  44. Friday Morning Movers: Amazon Pops, Deckers Outdoor Plummets ...

    Benzinga
  45. Stock Futures Sharpen Losses; Amazon, Visa, MasterCard Climb

    IBD
  46. Benzinga's Top #PreMarket Gainers

    Benzinga
  47. INTERCEPT PHARMACEUTICALS

    IBD
  48. Deutsche Bank: No Big Move In FY15 For Intercept Pharmaceuticals

    Benzinga
  49. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  50. Gilead Acquires Drug Program For Fatty Liver Disease

    IBD
  51. IPO Stock Watch: FibroGen Up With Liver-Disease Field

    IBD
  52. Making Money With Charles Payne: 12/22/14

    FoxBusiness
  53. Intercept Announces Publication Of Meta-Analysis From The Global ...

    Benzinga
  54. Here Are The Top 25 Analysts On Wall Street

    Benzinga
  55. Stock Movers: Why Medicals Issues Are Dipping Today

    IBD
  56. Mid-Afternoon Market Update: Lions Gate Surges On Earnings Beat; ...

    Benzinga
  57. Midday Losers From November 7: Roka Bioscience, Salix Pharmaceuticals, ...

    Benzinga
  58. Morning Market Losers

    Benzinga
  59. Benzinga's Top #PreMarket Losers

    Benzinga
  60. Meet The 5 Companies Loving Obamacare

    Benzinga
  61. Morning Market Losers

    Benzinga
  62. Benzinga's Top #PreMarket Losers

    Benzinga
  63. Benzinga's Top Initiations

    Benzinga
  64. Cowen Initiates Intercept At Outperform

    Benzinga
  65. Four biotech takeover targets?

    IBD
  66. 4 Biotechs That Might Be Bought Soon

    IBD
  67. InterMune Stock Spikes On Rare Big Biotech Buyout

    IBD
  68. Morning Market Losers

    Benzinga
  69. Benzinga's Top #PreMarket Losers

    Benzinga
  70. CNBC's Stock Pops & Drops From August 12

    Benzinga
  71. Markets Marginally Lower In Quiet Trading Session

    Benzinga
  72. U.S. Job Openings Climb; Leerink Swann Bullish On Intercept Pharmaceuticals

    Benzinga
  73. U.S. Stocks Fall; Dealertrack Shares Surge On Upbeat Results

    Benzinga
  74. Markets Mostly Flat; Flowers Foods Profit Misses Estimates

    Benzinga
  75. Stocks Stake Out Thin Gains; Intercept, Insys, Autohome Gain

    IBD
  76. Intercept Pharma Soars On Liver-Disease Drug Data

    IBD
  77. Benzinga's Volume Movers

    Benzinga
  78. Morning Market Movers

    Benzinga
  79. Conatus Shares Move Higher On Industry Data

    Benzinga
  80. Stock Futures Hem And Haw; Intercept Pharmaceuticals Soars

    IBD
  81. Benzinga's Top #PreMarket Gainers

    Benzinga
  82. Intercept Pharma Soars On Positive Liver Drug Data

    IBD
  83. INTERCEPT PHARMACEUTICALS

    IBD
  84. Intercept Pharmaceutical's Shares Soar On Earnings

    Benzinga
  85. Steven Cohen Has a Track Record of Impressive Returns

    GuruFocus
  86. Intercept Pharmaceutical Shares Up Amid Deutsche Bank Initiation

    Benzinga
  87. Markets Little Changed Ahead Of 4th Of July Break

    Benzinga
  88. Benzinga's Top Initiations

    Benzinga
  89. Analysts Comment On Intercept Amid Share Decline Following FLINT ...

    Benzinga
  90. Top Healthcare Movers For June 9, 2014

    Benzinga
  91. Market Wrap For April 14: Markets Surge on Positive Retail Data, ...

    Benzinga
  92. Weekly CFO Sells Highlight: Intercept Pharmaceuticals Inc., ...

    GuruFocus
  93. Intercept Issues Preclinical Data Showing OCA's Potential Role ...

    Benzinga
  94. US Stock Futures Nudge Higher Ahead Of Jobs Data

    Benzinga
  95. Market Wrap For March 17: Investors Focused On Economic Data ...

    Benzinga
  96. Intercept Pharmaceuticals Announces Q4 Earnings

    Benzinga
  97. Stocks Near Session Highs; Kandi Up 26% On Q4 Results

    IBD
  98. Top Trending Tickers On StockTwits For March 17

    Benzinga
  99. Benzinga's Top #PreMarket Losers

    Benzinga
  100. Morning Gainers for Friday, March 14, 2014

    Benzinga
Trading Center